Soltis Investment Advisors LLC Has $977,000 Stake in Colgate-Palmolive (NYSE:CL)

Soltis Investment Advisors LLC lifted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 374.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,745 shares of the company’s stock after buying an additional 8,480 shares during the quarter. Soltis Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $977,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of CL. CWM LLC grew its position in shares of Colgate-Palmolive by 28.7% during the 3rd quarter. CWM LLC now owns 35,216 shares of the company’s stock worth $3,656,000 after buying an additional 7,861 shares during the period. Livforsakringsbolaget Skandia Omsesidigt grew its position in shares of Colgate-Palmolive by 386.3% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 6,546 shares of the company’s stock worth $679,000 after buying an additional 5,200 shares during the period. Annex Advisory Services LLC grew its position in shares of Colgate-Palmolive by 13.7% during the 3rd quarter. Annex Advisory Services LLC now owns 3,955 shares of the company’s stock worth $411,000 after buying an additional 476 shares during the period. Koshinski Asset Management Inc. grew its position in shares of Colgate-Palmolive by 15.4% during the 3rd quarter. Koshinski Asset Management Inc. now owns 7,734 shares of the company’s stock worth $803,000 after buying an additional 1,034 shares during the period. Finally, Gilman Hill Asset Management LLC grew its position in shares of Colgate-Palmolive by 11.4% during the 3rd quarter. Gilman Hill Asset Management LLC now owns 2,447 shares of the company’s stock worth $254,000 after buying an additional 250 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $85.94 on Tuesday. The company’s fifty day simple moving average is $90.36 and its 200-day simple moving average is $96.77. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The firm has a market cap of $70.21 billion, a PE ratio of 24.41, a P/E/G ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the firm earned $0.87 EPS. Equities research analysts expect that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.33%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CL. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. UBS Group decreased their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Morgan Stanley decreased their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Stifel Nicolaus decreased their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.